Sally E. Abu‐Risha
- Pharmacology top 10%
- Drug-Induced Hepatotoxicity and Protection 5
-
- Neonatal Health and Biochemistry 5
-
- Neonatal Respiratory Health Research 5
- Respiratory Support and Mechanisms 3
-
- Liver Disease Diagnosis and Treatment 4
-
- Inflammatory Bowel Disease 4
-
- Cytokine Signaling Pathways and Interactions 4
-
- Nanoparticles: synthesis and applications 3
Sally E. Abu‐Risha
43 papers receiving 535 citations
Peers
Comparison fields: 5 of 93
- Pharmacology 48
- Complementary and alternative medicine 40
- Molecular Medicine 18
- Cancer Research 53
- Clinical Biochemistry 21
Countries citing papers authored by Sally E. Abu‐Risha
This map shows the geographic impact of Sally E. Abu‐Risha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally E. Abu‐Risha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally E. Abu‐Risha more than expected).
Fields of papers citing papers by Sally E. Abu‐Risha
This network shows the impact of papers produced by Sally E. Abu‐Risha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally E. Abu‐Risha. The network helps show where Sally E. Abu‐Risha may publish in the future.
Co-authorship network
The 24 scholars most cited alongside Sally E. Abu‐Risha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 8 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 23 | |
| 10 | 2022 | 13 | |
| 11 | 2022 | 8 | |
| 12 | 2021 | 26 | |
| 13 | 2021 | 35 | |
| 14 | 2020 | 29 | |
| 15 | 2020 | 70 | |
| 16 | 2020 | 5 | |
| 17 | 2020 | 5 | |
| 18 | 2020 | 1 | |
| 19 | 2020 | 14 | |
| 20 | 2016 | 86 |
About Sally E. Abu‐Risha
Sally E. Abu‐Risha is a scholar working on Pharmacology, Endocrine and Autonomic Systems and Pediatrics, Perinatology and Child Health, having authored 45 papers that have together received 542 indexed citations. Recurring topics across this work include Neonatal Health and Biochemistry (5 papers), Neonatal Respiratory Health Research (5 papers), Drug-Induced Hepatotoxicity and Protection (5 papers), Liver Disease Diagnosis and Treatment (4 papers), Inflammatory Bowel Disease (4 papers), Cytokine Signaling Pathways and Interactions (4 papers), Respiratory Support and Mechanisms (3 papers) and Nanoparticles: synthesis and applications (3 papers). The work is most often cited by research in Pharmacology (48 citations), Complementary and alternative medicine (40 citations) and Molecular Medicine (18 citations). Sally E. Abu‐Risha has collaborated with scholars based in Egypt, Saudi Arabia and Oman. Frequent co-authors include Alaa E. El‐Sisi, Ashraf M. Emara, Abdelhadi M. Shebl, Aya H. El-Kadem, Hanaa A. Ibrahim, Mohamed F. Hamed, Manar G. Helal, Manar A. Nader, Marwa E. Abdelmageed and Elsayed I. Salim. Their work appears in journals such as Scientific Reports, Life Sciences and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.